[Effect of a new cerebral vasodilator agent, viquidil, on the aggregation of blood platelets].
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000818:Animals; D001792:Blood Platelets / Q000187:drug effects*; D002449:Cell Aggregation / Q000187:drug effects; D003094:Collagen / Q000494:pharmacology; D004285:Dogs; D004837:Epinephrine / Q000494:pharmacology; D006801:Humans; D007659:Ketones / Q000097:blood / Q000494:pharmacology; D008297:Male; D010208:Papaverine / Q000097:blood / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology*; D011804:Quinolines / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000097:blood / Q000494:pharmacology*; D014753:Vinyl Compounds / Q000097:blood / Q000494:pharmacology
D007659:Ketones; D010880:Piperidines; D011804:Quinolines; D014665:Vasodilator Agents; D014753:Vinyl Compounds; D000244:Adenosine Diphosphate; D003094:Collagen; D010208:Papaverine; D004837:Epinephrine
Action in vitro d'un nouveau vasodilatateur cérébral, viquidil, sur l'aggŕegation des plaquettes sanguines.